Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Dotti AZ, Magro DO, Vilela EG, Chebli JMF, Chebli LA, Steinwurz F, Argollo M, Carvalho NS, Parente JML, Lima MM, Parra RS, Perin RL, Flores C, Morsoletto EM, da Costa Ferreira S, Ludvig JC, Kaiser Junior RL, Faria MAG, Nicollelli GM, Andrade AR, Queiroz NSF, Kotze PG. Dotti AZ, et al. Among authors: ludvig jc. Crohns Colitis 360. 2023 Sep 22;5(4):otad053. doi: 10.1093/crocol/otad053. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37859629 Free PMC article.
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.
Perin RL, Magro DO, Andrade AR, Argollo M, Carvalho NS, Damião AOMC, Dotti AZ, Ferreira SDC, Flores C, Ludvig JC, Nones RB, Queiroz NSF, Parra RS, Steinwurz F, Teixeira FV, Kotze PG. Perin RL, et al. Among authors: ludvig jc. Crohns Colitis 360. 2022 Dec 19;5(1):otac050. doi: 10.1093/crocol/otac050. eCollection 2023 Jan. Crohns Colitis 360. 2022. PMID: 36777366 Free PMC article.
ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY.
Zacharias P, Damião AOMC, Moraes AC, Teixeira FV, Ludvig JC, Nones RB, Saad-Hossne R, Sassaki LY, Silva RPLD, Facchin L, Olandoski M, Kotze PG. Zacharias P, et al. Among authors: ludvig jc. Arq Gastroenterol. 2017 Dec;54(4):321-327. doi: 10.1590/S0004-2803.201700000-51. Epub 2017 Oct 2. Arq Gastroenterol. 2017. PMID: 28977114 Free article.
INFLAMMATORY BOWEL DISEASE CARE IN BRAZIL: HOW IT IS PERFORMED, OBSTACLES AND DEMANDS FROM THE PHYSICIANS' PERSPECTIVE.
Vilela EG, Rocha HC, Moraes AC, Santana GO, Parente JM, Sassaki LY, Miszputen SJ, Quaresma AB, Clara APHS, Jesus ACS, Pinto ADS, Silva BLPSD, Silva BCD, Freire CCF, Santos CHMD, Brito C, Teixeira EFL, Miranda EF, Zabot GP, Duarte JL, Ludvig JC, Campos-Lobato LF, Cassol OS, Souza MM, Almeida NP, Parra RS, Lima JÚnior SF, Saad-Hossne R. Vilela EG, et al. Among authors: ludvig jc. Arq Gastroenterol. 2020 Oct-Dec;57(4):416-427. doi: 10.1590/S0004-2803.202000000-77. Arq Gastroenterol. 2020. PMID: 33331475 Free article.
Consensus guidelines for the management of inflammatory bowel disease.
Brazilian Study Group of Inflammatory Bowel Diseases. Brazilian Study Group of Inflammatory Bowel Diseases. Arq Gastroenterol. 2010 Jul-Sep;47(3):313-25. doi: 10.1590/s0004-28032010000300019. Arq Gastroenterol. 2010. PMID: 21140096 Free article.